Indian pharmaceutical companies Cipla and Ranbaxy under an agreement with the Clinton Foundation will reduce the prices of 19 different pediatric antiretroviral drugs in 62 developing countries to an average of 45% less than what treatments currently cost in the countries...One of the formulations, a new three-in-one treatment for children, will cost about 16 cents per day, or $60 annually...